Novonesis (Novozymes) B (0Q4U) - Analysis

opens in 2d 4h 38m

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,051.68 -0.10%
EUR/USD 1.15 0.03%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.60 -0.03%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,051.68 -0.10%
EUR/USD 1.15 0.03%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.60 -0.03%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,051.68 -0.10%
EUR/USD 1.15 0.03%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.60 -0.03%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,051.68 -0.10%
EUR/USD 1.15 0.03%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.60 -0.03%
XPT/USD 1,003.20 0.33%

387.75 DKK

0

0%

Last update Apr 1, 3:59 PM BST

Market closed

Day range

387.75

387.75

387.75

Previous close

387.75

Open

387.75

Access this stock data via API

Novonesis (Novozymes) B

387.75

0

0%

Analysis

Growth estimates
Current qtr (Apr 2026)	0.268%
Next qtr. (Jul 2026)	0.077%
Current year (2026)	0.133%
Next 5 years (per annum)	0.084%
Past 5 years (per annum)	0.025%

Access /growth_estimates data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.

Access /recommendations data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.

Analyst ratings

Firm	Date	Action
JP Morgan	Mar 26, 2019	Downgrade
Jefferies	Aug 07, 2015	Maintains

Access /analyst_ratings/light data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.